Ipath Series B Etf Probability Of Bankruptcy

VXX Etf  USD 13.57  0.14  1.02%   
IPath Series' risk of distress is under 9% at this time. It has tiny likelihood of undergoing some form of financial hardship in the near future. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. Check out IPath Series Piotroski F Score and IPath Series Altman Z Score analysis.
  

iPath Series B ETF probability of bankruptcy Analysis

IPath Series' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current IPath Series Probability Of Bankruptcy

    
  Less than 9%  
Most of IPath Series' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iPath Series B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of IPath Series probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting IPath Series odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of iPath Series B financial health.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, iPath Series B has a Probability Of Bankruptcy of 9.0%. This is much higher than that of the Milleis Investissements Funds family and significantly higher than that of the Trading--Miscellaneous category. The probability of bankruptcy for all United States etfs is notably lower than that of the firm.

IPath Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IPath Series' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of IPath Series could also be used in its relative valuation, which is a method of valuing IPath Series by comparing valuation metrics of similar companies.
IPath Series is currently under evaluation in probability of bankruptcy as compared to similar ETFs.

IPath Fundamentals

About IPath Series Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze iPath Series B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IPath Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iPath Series B based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

IPath Series Implied Volatility

    
  84.44  
IPath Series' implied volatility exposes the market's sentiment of iPath Series B stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if IPath Series' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that IPath Series stock will not fluctuate a lot when IPath Series' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IPath Series in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IPath Series' short interest history, or implied volatility extrapolated from IPath Series options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:
Check out IPath Series Piotroski F Score and IPath Series Altman Z Score analysis.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.